GlaxoSmithKline Intellectual Property Development Limited
发明人:
Scott B. BERGER,Peter J. GOUGH,Kathleen M. WEISEL
申请号：
US15505272
公开号：
US20170266199A1
申请日:
2015.08.20
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Disclosed is a method of treating a RIP1 kinase-mediated disease or disorder which comprises administering a therapeutically effective amount of a compound that inhibits RIP1 kinase and at least one other therapeutically active agent to a patient in need thereof.
